Company intelligence / Profile preview

Evoke Neuroscience

Jacksonville, North Carolina, United States

Ownership: Private
Employees: ~20
Development stage: Other

Overview

Evoke Neuroscience's eVox® Brain Health System has performed over 100,000 assessments and is FDA 510(k) cleared to aid in the diagnosis of cognitive impairment in clinical environments; the system is used for objective EEG/ERP-based brain health scans with integration of AI/machine learning algorithms for early detection, especially in Alzheimer's and other cognitive disorders[1][3][9].

Therapeutic areas: NeurologyPsychiatry
Modalities: DeviceNon-pharmacological therapyDigital biomarkerComputational EEG
Industry: Physiological Monitoring

Partnerships

Pacific Neuroscience Institute/Providence Saint John’s Health Center (collaborative studies/clinical validation)[4]U.S. Veteran Affairs (contract award)[1]Premier GPO (technology adoption)

Beyond the preview

Go deeper on Evoke Neuroscience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Evoke Neuroscience.

Explore the full profile